Session 6D | Expanding Access: Equity, Innovation and Capacity in AOD Care
Tracks
.
| Tuesday, November 11, 2025 |
| 4:00 PM - 5:30 PM |
| C2.1 |
Details
Chair: John Gobeil
Speaker
Dr Michael Curtis
Research Fellow
NDRI, Curtin University
Opioid agonist treatment price, coverage and retention after Pharmaceutical Benefit Scheme subsidisation reforms among a cohort of people who inject drugs in Melbourne, Australia: Preliminary results.
4:00 PM - 4:10 PMBiography
Dr Michael Curtis is a Research Associate at the National Drug Research Institute, Curtin University and the Burnet Institute. His research interests include using longitudinal observational cohort data and administrative datasets to improve the health and wellbeing of people who use drugs. Previously, Michael worked as a social worker.
Associate Professor Geoffrey Spurling
Associate Professor
The University Of Queensland
Access denied: How policy constructions of harms and risk place opioid pharmacotherapy beyond the usual business of primary care
4:10 PM - 4:20 PMBiography
A/Proff Geoff Spurling is an NHMRC Emerging Leader (2020-2024) and a senior GP at the Southern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander primary care (2004-present) where he has been prescribing opioid dependence treatment since 2021. His research focus is ensuring equitable access to primary health care.
Bek Petrovic
Researcher
Burnet Institute
Is there reproductive equity and choice? Contraception use among women who inject drugs
4:20 PM - 4:25 PMBiography
Bek leads the fieldwork team within the Alcohol and Other Drug (AOD) working group at Burnet Institute, coordinating data collection for a community-based study of over 1,500 people who inject drugs in Melbourne. She has a special interest in women’s sexual and reproductive health, particularly among women who use drugs.
Dr Clara Dawkins
Medical Officer
Te Whatu Ora
Testing for sexually transmitted infections (STIs) in Addiction Services: reducing barriers to access for priority populations.
4:25 PM - 4:30 PMBiography
Dr Dawkins is a GP and Addiction Medicine Advanced Trainee based in Auckland, New Zealand. Her work focuses on harm reduction and public health. She is researching STI screening in addiction services. Her work improves equity by strengthening the interface between primary and secondary care.
Dr Michelle Black
Research Project Officer
Nada
Building Research and Evaluation Capacity in Non-Government Organisations in the Alcohol and Other Drugs Sector in New South Wales.
4:30 PM - 4:35 PMBiography
Michelle is a Research Capacity Project Officer at NADA with a PhD in health sociology. She was previously a senior lecturer at ACU, and has held research roles across NGOs and health services including DAMEC and Family Planning NSW. Michelle also draws on her lived experience in her work.
APSAD 2025
Session 6D Q&A
4:35 PM - 4:45 PMBiography
APSAD 2025
Ms Nadia Gavin
Program & Services Manager
Harm Reduction Victoria
Panel Member
4:45 PM - 5:30 PMBiography
Natasha Nikolic
Panel Member
4:45 PM - 5:30 PMBiography
Ms Nicola Parry
Peer Leader
QUIHN & QUIVAA
Panel Member
4:45 PM - 5:30 PMBiography
Ms Peta Gava
Overdose Prevention Project Officer and Communications and Reporting Officer
Peer Based Harm Reduction WA
Panel Member
4:45 PM - 5:30 PMBiography
Ms Alice Ruby Pierce
Director Of Programs
NUAA
Panel Member
4:45 PM - 5:30 PMBiography
Chair
Johnathan Gobeil
CEO
AIVL